Literature DB >> 16265971

Employee assistance programs in the new millennium.

Dale A Masi1.   

Abstract

This article presents an overall view of Employee Assistance Programs (EAPs). Beginning with the history, this article describes various models and essential ingredients of EAPs. It then discusses current trends including integration with Work/Life, web-based services, EAP accreditation, and the growth of international programs. Several issues are discussed including the need for licensing done nationally rather than by states and the effect the lack of substance abuse and brief counseling education has had on the delivery of EAP services. Future directions for EAPs emphasize the importance of quality assurance and the development of performance measurements, performance guarantees, and outcome measurements. The formation of the Alliance for Employee Assistance Advancement, an organization of organizations, completes the description and shows a new direction for EAPs in the next millennium.

Entities:  

Mesh:

Year:  2005        PMID: 16265971

Source DB:  PubMed          Journal:  Int J Emerg Ment Health        ISSN: 1522-4821


  3 in total

1.  Integrated employee assistance program/managed behavioral health plan utilization by persons with substance use disorders.

Authors:  Elizabeth S Levy Merrick; Dominic Hodgkin; Deirdre Hiatt; Constance M Horgan; Shelly F Greenfield; Bernard McCann
Journal:  J Subst Abuse Treat       Date:  2010-12-24

2.  Trial of the university assistance program for alcohol use among mandated students.

Authors:  Hortensia Amaro; Marilyn Ahl; Atsushi Matsumoto; Guillermo Prado; Christina Mulé; Amaura Kemmemer; Mary E Larimer; Dale Masi; Philomena Mantella
Journal:  J Stud Alcohol Drugs Suppl       Date:  2009-07

3.  Alcohol & drug abuse: Revisiting employee assistance programs and substance use problems in the workplace: key issues and a research agenda.

Authors:  Elizabeth S Levy Merrick; Joanna Volpe-Vartanian; Constance M Horgan; Bernard McCann
Journal:  Psychiatr Serv       Date:  2007-10       Impact factor: 3.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.